FDA Approves AOP Health’s Rapiblyk for Atrial Fibrillation and Atrial Flutter
Approval was based on the combined results from five studies of adults with supraventricular tachycardia.
August 16, 2026
Approval was based on the combined results from five studies of adults with supraventricular tachycardia.